Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Cash from Operations: 2019-2025

Historic Cash from Operations for Benitec Biopharma (BNTC) over the last 7 years, with Jun 2025 value amounting to -$23.6 million.

  • Benitec Biopharma's Cash from Operations fell 149.77% to -$8.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$23.6 million, marking a year-over-year decrease of 21.63%. This contributed to the annual value of -$23.6 million for FY2025, which is 21.63% down from last year.
  • As of FY2025, Benitec Biopharma's Cash from Operations stood at -$23.6 million, which was down 21.63% from -$19.4 million recorded in FY2024.
  • Benitec Biopharma's Cash from Operations' 5-year high stood at -$12.8 million during FY2021, with a 5-year trough of -$23.6 million in FY2025.
  • Its 3-year average for Cash from Operations is -$20.3 million, with a median of -$19.4 million in 2024.
  • Data for Benitec Biopharma's Cash from Operations shows a maximum YoY plummeted of 70.30% (in 2021) over the last 5 years.
  • Benitec Biopharma's Cash from Operations (Yearly) stood at -$12.8 million in 2021, then declined by 23.91% to -$15.9 million in 2022, then declined by 13.28% to -$18.0 million in 2023, then decreased by 7.72% to -$19.4 million in 2024, then decreased by 21.63% to -$23.6 million in 2025.